E-Minerva Preloader

7° NUTRACEUTICA E OCCHIO

ROMA, 17 ottobre 2020

Aule del building Facoltà di Medicina e Psicologia presso Ospedale Sant’Andrea

SEGRETERIA ORGANIZZATIVA:

Email: info@jaka.it

www.jaka.it

SEGRETERIA SCIENTIFICA:

Dott.ssa Serena Fragiotta,
Dott. Luca Scuderi

PROGRAMMA

Progress in Gene Therapy

Professor Christof von Kalle

Charité University of Medicine, Berlin Institute of Health Translational Medicine Unit Berlin, Germany

View profile

What were the different types of gene therapy and vectors used in red blood cell disorders?

Could you describe the safety profile of lentiviral vectors?

What were some of the key milestones in the development of gene terapies?

How do regulatory bodies view lentiviral gene therapy?

What are the main safety considerations to bear in mind with gene therapy?

What are the key elements of successful gene therapy?

What is the actual role of the vectors used in gene terapy?

What is the relationship between vector copy number and expression of haemoglobin?

What is a Lentiviral Vector?

For medical information enquiries, please contact medinfo@bluebirdbio.com